Back to News
Market Impact: 0.1
After-Hours Earnings Report for September 21, 2026 : ABVX
Source: Nasdaq
Corporate EarningsHealthcare & BiotechAnalyst Estimates
Abivax SA (ABVX), a gene-focused biopharmaceutical company, is expected to report earnings after the market close on September 21, 2026, for the quarter ended June 30, 2026. The article is an earnings-calendar notice and provides no complete consensus EPS figure, operating results, guidance, or material company update.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
ABVX0.00
More News
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- AI stocks hammered by midterm shock as data center buildout becomes a 'war of attrition'
- As tech swoon roils market, US inflation data on tap
- FTSE 100 today: Stocks slump as global tech rout deepens
- Needham reiterates Hold on Blink Charging stock after Q3 results
- Solventum stock price target raised to $100 by BTIG on results